The hitchhiker's guide to ketamine-induced cystitis
Ketamine, widely used as an anesthetic since the 1970s, recently gained U.S. Food and Drug Administration (FDA) approval for treatment-resistant depression as a nasal spray. The use of off-label IV ketamine for pain relief, depression, and suicidal ideation has yielded promising results, but the con...
Main Author: | Siegelman, Nicolas Anthony |
---|---|
Other Authors: | Spencer, Jean L. |
Language: | en_US |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/41733 |
Similar Items
-
Ketamine-snorting associated cystitis
by: Chung-Hsien Chen, et al.
Published: (2011-12-01) -
Burden of ketamine cystitis in Chinese society
by: Wai-Kit Ma, et al.
Published: (2015-09-01) -
Intravesical hyaluronic acid treatment for ketamine-associated cystitis: Preliminary results
by: En Meng, et al.
Published: (2015-09-01) -
Ketamine cystitis: Its urological impact and management
by: Yao Chou Tsai, et al.
Published: (2015-09-01) -
Mast cells infiltration and decreased E-cadherin expression in ketamine-induced cystitis
by: Mengqiang Li, et al.
Published: (2015-01-01)